 Successful strategy prevention cytomegalovirus interstitial pneumonia human leukocyte antigen-identical bone marrow transplantation Cytomegalovirus CMV interstitial pneumonia frequent fatal complication allogeneic bone marrow transplantation therapy CMV pneumonia ineffective prophylactic methods study strategy CMV seronegative blood products seronegative patients seronegative donors weekly administration intravenous immunoglobulin patients attack rate CMV pneumonia results study perspective data